positive inotropic agent

positive inotropic agent

Cardiology An agent–eg, digoxin, gitalin, lanatoside, beta-adrenoceptor agonists that ↑ force and velocity of myocardial contractility
References in periodicals archive ?
As such, our study results seem to suggest that determination of baseline IGF-I levels may help guide clinicians when making the decision to administer a positive inotropic agent such as levosimendan in patients admitted with a diagnosis of decompensated HE In this study, we only assessed short-term response to levosimendan treatment.
A positive inotropic agent that simultaneously activates intracellular [K.
When intravenous vasoactive medications are required for acute decompensated heart failure, patients who receive a vasodilator or natriuretic peptide are more likely to survive than are those who receive a positive inotropic agent, reported William T.
This herb is a positive inotropic agent that increases contractility of the heart," said Dr.
Intravenous enoximone is a positive inotropic agent indicated for the treatment of acute decompensated heart failure and various uses in the cardiac surgery setting.
The company is currently evaluating two drugs in human clinical studies: enoximone, a positive inotropic agent that increases the force of contraction of the heart, and ambrisentan, a member of a new class of drugs referred to as endothelin receptor antagonists, which the Company intends to develop for the treatment of chronic heart failure, chronic renal failure, and pulmonary arterial hypertension.
The company is currently evaluating two drugs in human clinical studies: enoximone, a positive inotropic agent that increases the force of contraction of the heart, and BSF 208075, a member of a new class of drugs referred to as endothelin receptor antagonists, which the Company intends to develop for the treatment of chronic heart failure, chronic renal failure, and pulmonary arterial hypertension.
Enoximone is a positive inotropic agent that increases the force of contraction of the heart.
Myogen acquired enoximone, a positive inotropic agent for the treatment of advanced heart failure, from Aventis in 1998.
New positive inotropic agents with higher safety margins and stronger effects on cardiac contractility have been introduced in human and veterinary cardiology during the last 20 years (3) and their use must be explored in the avian patient.
For cardiologists, internists, and others, specialists from the US, India, and Guatemala emphasize advances in the understanding of coronary circulation, the molecular mechanisms of myocyte function, and the assessment of regional and global ventricular functions in physiologic and pathologic conditions, and address advances in cardiovascular pharmacology, including the advantages and disadvantages of diuretic therapy, vasodilators, neurohormone modulators, positive inotropic agents, and antilipid, antithrombotic, and antiplatelet agents, and their clinical pharmacology in the management of various cardiovascular disorders.
5) For those persons with advanced HF or ADHF, tailored therapy often includes the addition of positive inotropic agents such as dobutamine.

Full browser ?